Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2024

Mar 17, 2024

65058_rns_2024-03-17_f43ba9e5-df16-43e7-a174-f5ad0f8617fc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Sally Evans
Date of last notice 20 December 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving
rise to the relevant interest.
As shown
Date of change 15 March 2024
No. of securities held prior to
change
44,439 Ordinary Shares
Sally Evans
19,110 Ordinary Shares
RBC Investor Services Australia
Nominees Pty Ltd

32,900 NED Share Rights
Sally Evans
_
34,882 Shares are subject to a holding lock as “Restricted Securities” under the_
NED Share Plan.
Class Ordinary Shares
Number acquired 16,450
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details
and estimated valuation
$25,000 cash equivalent using the volume weighted average
price of Ordinary Shares over the five business days immediately
following the Healius Limited Annual General Meeting on 28
November 2023, being $1.5197 per security
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after
change
51,332 NED Restricted
Ordinary Shares
9,557 Ordinary Shares
Sally Evans
Sally Evans
19,110 Ordinary Shares
RBC Investor Services Australia
Nominees Pty Ltd

16,450 NED Share Rights
Sally Evans
Nature of change
Example:
on-market
trade,
off-market
trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in buy-
back
Vesting of NED Share Rights issued in respect of FY24 into
Ordinary Shares (restricted) under the NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 18 March 2024

  • See chapter 19 for defined terms.

Appendix 3Y Page 2